Comparative Study inTreatment of Trigeminal Neuralgia

Comparative Study Between Microvascular Decompression and Percutaneous Radiofrequency Rhizotomy for Treatment of Trigeminal Neuralgia

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04801407

Enrollment

Registered

2021-03-17

Start date

2021-03-31

Completion date

2022-06-30

Last updated

2021-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal Neuralgia

Keywords

trigeminal neuralgia

Brief summary

This study aims to evaluate the results of percutaneous radiofrequency rhizotomy and the effectiveness of microvascular decompression for the treatment of trigeminal neuralgia and Comparing between them according the different outcome parameters.

Detailed description

This is prospective case -series hospital based study, will be conducted on 40 patients with trigeminal neuralgia treated either by percutaneous radiofrequency trigeminal rhizotomy or microvascular decompression at Sohag University Hospitals, between march 2021 and June 2022 and we will divide the the patients into two groups ,one group will be treated with percutaneous radiofrequency trigeminal rhizotomy and the other group will be treated with microvascular decompression and we will asses the results with the Barrow Neurological Institute Pain Intensity Score .

Interventions

PROCEDUREpercutaneous radiofrequency trigeminal rhizotomy

percutaneous radiofrequency trigeminal rhizotomy is a perctaneous procedure that ablate the sensory part of the nerve and

PROCEDUREMicrovascular decompression of the trigeminal nerve

Microvascular decompression is a procedure that decompress the nerve from vascular conflict

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Intervention model description

prospective case -series hospital based study

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Failed medical treatment more than 6 months

Exclusion criteria

* Coagulation disorder or hemorrhagic disease; * Mental illness and inability to cooperate;

Design outcomes

Primary

Measure	Time frame	Description
Barrow Neurological Institute Pain Intensity Score	3 months	I (no pain, no medication), II (occasional pain, not requiring medication), III (some pain, controlled with medication), IV (some pain, not controlled with medication) V (severe pain, no pain relief with medication).

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026